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Summary
Similar to most Gram-negative bacteria, the outer
leaﬂet of the outer membrane of Vibrio cholerae is
comprised of lipopolysaccharide. Previous reports
have proposed that V. cholerae serogroups O1 and
O139 synthesize structurally different lipidAdomains,
which anchor lipopolysaccharide within the outer
membrane. In the current study, intact lipid A species
of V. cholerae O1 and O139 were analysed by mass
spectrometry. We demonstrate that V. cholerae sero-
groups associated with human disease synthesize a
similar asymmetrical hexa-acylated lipid A species,
bearing a myristate (C14:0) and 3-hydroxylaurate
(3-OH C12:0) at the 2- and 3-positions respectively.A
previous report from our laboratory characterized the
V. cholerae LpxL homologue Vc0213, which transfers
a C14:0 to the 2-position of the glucosamine disac-
charide. Our current ﬁndings identify V. cholerae
Vc0212 as a novel lipid A secondary hydroxy-
acyltransferase, termed LpxN, responsible for trans-
ferring the 3-hydroxylaurate (3-OH C12:0) to the
V. cholerae lipid A domain. Importantly, the presence
of a 3-hydroxyl group on the 3-linked secondary acyl
chain was found to promote antimicrobial peptide
resistance in V. cholerae; however, this functional
group was not required for activation of the innate
immune response.
Introduction
The Gram-negative bacterium Vibrio cholerae is the
causative agent of the acute diarrheal disease cholera.
Cholera is caused by the ingestion of contaminated food
or water, causing rapid dehydration, and ultimately result-
ing in death when left untreated. V. cholerae thrive in
marine environments and are readily found in temperate
ocean waters. Within its aquatic environment more than
200 serogroups of V. cholerae have been identiﬁed;
however, only V. cholerae strains bearing the lipopolysac-
charide (LPS) somatic antigens O1 or O139 have been
associated with pandemic disease (Mooi and Bik, 1997).
Lipopolysaccharide is the major constituent in the
Gram-negative outer membrane and is composed of
three regions: the lipidAdomain, the core oligosaccharide
and the O-antigen polysaccharide (Raetz and Whitﬁeld,
2002). The core oligosaccharide consists of inner and
outer core regions. The inner core is composed of 3-
deoxy-D-manno-octulosonic acid (Kdo) residues, which
link the lipid A domain to the remainder of the core oli-
gosaccharide and O-antigen. Lipid A is responsible for
anchoring LPS within the outer membrane of Gram-
negative bacteria. Importantly, the lipid A domain is the
bioactive portion of LPS and stimulates the host innate
immune system through the activation of Toll-like receptor
4/myeloid differentiation factor 2 (TLR4/MD-2). Lipid A
biosynthesis is a well-conserved and ordered process
among Gram-negative bacteria (Raetz and Whitﬁeld,
2002; Trent et al., 2006; Raetz et al., 2007). Despite the
preservation of the Kdo-lipid A biosynthetic pathway,
many diverse lipid A structures are produced by various
pathogens, promoting survival during infection (Trent
et al., 2006).
Kdo-lipid A synthesis in Escherichia coli results in a
hexa-acylated b-1′,6-linked disaccharide of glucosamine
with unmodiﬁed phosphate groups at the 1- and 4′-
positions (Fig. 1A) (Raetz and Whitﬁeld, 2002). During
the late stages of E. coli Kdo-lipid A biosynthesis, the
Accepted 28 June, 2011. *For correspondence. E-mail strent@mail.
utexas.edu; Tel. (+1) (512) 232 8371; Fax (+1) (512) 471 7088.
Re-use of this article is permitted in accordance with the Terms
and Conditions set out at http://wileyonlinelibrary.com/onlineopen#
OnlineOpen_Terms
Molecular Microbiology (2011) 81(5), 1313–1329  doi:10.1111/j.1365-2958.2011.07765.x
First published online 18 July 2011
© 2011 Blackwell Publishing LtdF
i
g
.
1
.
C
o
m
p
a
r
i
s
o
n
o
f
t
h
e
l
a
t
e
s
t
a
g
e
s
o
f
K
d
o
-
l
i
p
i
d
A
b
i
o
s
y
n
t
h
e
s
i
s
i
n
E
.
c
o
l
i
a
n
d
V
.
c
h
o
l
e
r
a
e
.
A
.
E
.
c
o
l
i
p
o
s
s
e
s
s
a
b
i
-
f
u
n
c
t
i
o
n
a
l
K
d
o
t
r
a
n
s
f
e
r
a
s
e
(
K
d
t
A
,
a
l
s
o
k
n
o
w
n
a
s
W
a
a
A
)
,
w
h
i
c
h
t
r
a
n
s
f
e
r
s
t
w
o
K
d
o
s
u
g
a
r
s
t
o
t
h
e
l
i
p
i
d
A
p
r
e
c
u
r
s
o
r
l
i
p
i
d
I
V
A
.
T
h
e
l
i
p
i
d
A
s
e
c
o
n
d
a
r
y
a
c
y
l
t
r
a
n
s
f
e
r
a
s
e
s
,
L
p
x
L
a
n
d
L
p
x
M
t
h
e
n
c
a
t
a
l
y
s
e
t
h
e
t
r
a
n
s
f
e
r
o
f
a
l
a
u
r
a
t
e
(
C
1
2
:
0
)
(
b
l
u
e
)
t
o
t
h
e
2
′
-
p
o
s
i
t
i
o
n
a
n
d
a
m
y
r
i
s
t
a
t
e
(
C
1
4
:
0
)
(
r
e
d
)
t
o
t
h
e
3
′
-
p
o
s
i
t
i
o
n
o
f
t
h
e
g
l
u
c
o
s
a
m
i
n
e
d
i
s
a
c
c
h
a
r
i
d
e
,
c
r
e
a
t
i
n
g
K
d
o
2
-
l
i
p
i
d
A
.
B
.
T
h
e
V
.
c
h
o
l
e
r
a
e
g
e
n
o
m
e
e
n
c
o
d
e
s
a
m
o
n
o
-
f
u
n
c
t
i
o
n
a
l
K
d
t
A
,
w
h
i
c
h
t
r
a
n
s
f
e
r
s
o
n
e
K
d
o
r
e
s
i
d
u
e
t
o
l
i
p
i
d
I
V
A
.
T
h
e
K
d
o
k
i
n
a
s
e
(
K
d
k
A
)
t
h
e
n
p
h
o
s
p
h
o
r
y
l
a
t
e
s
t
h
e
K
d
o
s
u
g
a
r
(
g
r
e
e
n
)
,
r
e
s
u
l
t
i
n
g
i
n
p
h
o
s
p
h
o
r
y
l
a
t
e
d
K
d
o
-
l
i
p
i
d
I
V
A
.
V
.
c
h
o
l
e
r
a
e
L
p
x
L
(
V
c
0
2
1
3
)
c
a
t
a
l
y
s
e
s
t
h
e
t
r
a
n
s
f
e
r
o
f
a
m
y
r
i
s
t
a
t
e
(
C
1
4
:
0
)
(
b
l
u
e
)
t
o
t
h
e
2
′
-
p
o
s
i
t
i
o
n
o
f
t
h
e
g
l
u
c
o
s
a
m
i
n
e
d
i
s
a
c
c
h
a
r
i
d
e
.
A
s
s
h
o
w
n
i
n
t
h
e
c
u
r
r
e
n
t
w
o
r
k
,
L
p
x
N
(
V
c
0
2
1
2
)
t
r
a
n
s
f
e
r
s
a
3
-
h
y
d
r
o
x
y
l
a
u
r
a
t
e
(
3
-
O
H
C
1
2
:
0
)
(
r
e
d
)
t
o
t
h
e
3
′
-
p
o
s
i
t
i
o
n
,
g
e
n
e
r
a
t
i
n
g
t
h
e
h
e
x
a
-
a
c
y
l
a
t
e
d
V
.
c
h
o
l
e
r
a
e
K
d
o
-
l
i
p
i
d
A
d
o
m
a
i
n
.
T
h
e
e
x
a
c
t
o
r
d
e
r
i
n
w
h
i
c
h
t
h
e
s
e
c
o
n
d
a
r
y
a
c
y
l
c
h
a
i
n
s
a
r
e
a
d
d
e
d
i
n
V
.
c
h
o
l
e
r
a
e
h
a
s
n
o
t
b
e
e
n
d
e
t
e
r
m
i
n
e
d
.
1314 J. V. Hankins etal. 
© 2011 Blackwell Publishing Ltd, Molecular Microbiology, 81, 1313–1329bi-functional Kdo transferase KdtA (also known as WaaA)
catalyses the transfer of two Kdo residues to the lipid A
precursor, lipid IVA, creating Kdo2-lipid IVA (Fig. 1A)
(Clementz and Raetz, 1991). The addition of the Kdo
residues is essential for the activity of the secondary
acyltransferases LpxLand LpxM. LpxLand LpxM catalyse
the transfer of laurate (C12:0) to the 2′-position (Clementz
et al., 1996) and myristate (C14:0) to the 3′-position
(Clementz et al., 1997) of the Kdo2-lipid IVA precursor,
respectively, creating Kdo2-lipid A.
Previously, little attention has been given to Kdo-lipid
A biosynthesis in V. cholerae. The fatty acyl compositions
of LPS isolated from various V. cholerae serogroups
and biotypes have been characterized (Raziuddin and
Kawasaki, 1976; Raziuddin, 1977; Broady et al., 1981;
Kabir, 1982); however, a deﬁnitive Kdo-lipid A structure
remains unknown. Our laboratory has previously shown
that the late stages of V. cholerae Kdo-lipidAbiosynthesis
differ from that of E. coli (Hankins and Trent, 2009). The
V. cholerae genome encodes a mono-functional KdtA,
which catalyses the transfer of one Kdo residue to lipid IVA
(Fig. 1B). The V. cholerae Kdo kinase (KdkA) phosphory-
lates the Kdo residue, yielding phosphorylated Kdo-lipid
IVA. The transfer of the phosphate group by KdkA is
essential for the functionality of the V. cholerae LpxL
homologue, Vc0213 (Hankins and Trent, 2009), which
catalyses the transfer of a myristate (C14:0) residue
(Fig. 1B). Notably, phosphorylation of the Kdo sugar was
also shown to be required for the function of LpxL homo-
logues from Haemophlius inﬂuenzae and Bordetella per-
tussis (Hankins and Trent, 2009).
Interestingly, the V. cholerae genome encodes an addi-
tional secondary acyltransferase homologue annotated
as Vc0212. Our present study demonstrates that Vc0212
functions as a novel lipid A secondary acyltransferase
responsible for the transfer of a 3-hydroxylaurate (3-OH
C12:0) to the acyl chain linked at the 3′-position of
V. cholerae lipid A (Fig. 1B). Although the primary lipid A
acyltransferases, LpxA (Crowell et al., 1986; Kelly et al.,
1993) and LpxD (Kelly et al., 1993), catalyse the transfer
of b-hydroxyacyl chains from acyl–acyl carrier protein
(acyl-ACP) donors to the glucosamine backbone, a lipid
A secondary hydroxy-acyltransferase has not been
characterized. Given the unique substrate preference, we
propose that secondary hydroxy-acyltransferases be
given the lpx designation, LpxN.
While other Gram-negative bacteria have been shown
to possess hydroxylated secondary acyl chains, the
hydroxylation typically occurs at the 2-position of the sec-
ondary acyl chain following de novo synthesis of lipid A.
The incorporation of the hydroxyl group is catalysed by
LpxO, a membrane bound dioxygenase (Gibbons et al.,
2000; 2005). Therefore, our ﬁndings reveal a new mecha-
nism for the incorporation of secondary hydroxylated acyl
chains to the lipid A of Gram-negative organisms, sug-
gesting that the presence of a hydroxyl group may be
evolutionarily important for the stabilization of the outer
membrane. Our current data, in combination with our
previous work, also clarify the late stages of V. cholerae
Kdo-lipid A biosynthesis and deﬁne the lipid A structure of
V. cholerae serogroups O1 and O139.
Results
V. cholerae synthesize a hexa-acylated lipid A species
To date, no deﬁnitive lipid A structure has been deter-
mined for V. cholerae; however, a previous literature
review included proposed lipidAstructures for V. cholerae
O1 and O139 (Chatterjee and Chaudhuri, 2006) (Fig. S1).
Although earlier reports characterized the fatty acyl chain
composition of various V. cholerae strains (Armstrong and
Redmond, 1974; Raziuddin and Kawasaki, 1976; Raziud-
din, 1977; Broady et al., 1981), each investigation failed to
examine intact lipid A species of V. cholerae. In order to
elucidate the intact lipid A structure of V. cholerae, lipid A
species were isolated from V. cholerae serogroups O1 El
Tor (E7946 and C6706), O1 classical (O395) and O139
(MO10). Lipid A species were subjected to anion-
exchange chromatography as described in Experimental
procedures. Fractionated lipid A species were analysed
by matrix-assisted laser desorption/ionization-time of
ﬂight (MALDI-TOF) mass spectrometry (MS) in the nega-
tive ion mode (Fig. 2).
V. cholerae serogroups O1 El Tor and O139 displayed
more heterogeneity among lipid A species as compared
with the O1 classical biotype. V. cholerae O1 El Tor strains
produced a predominant peak at m/z 1755.4, while
V. cholerae O139 revealed a major peak at m/z 1756.3 in
fraction A (Fig. 2A and D, respectively). Both V. cholerae
O1 El Tor and O139 strains displayed a major peak at m/z
1813.1 in fraction B (Fig. 2B). MALDI-TOF analysis of the
lipid A isolated from the V. cholerae O1 classical biotype
revealed a predominant peak at m/z 1755.1 (Fig. 2C).
Because each V. cholerae strain examined was found to
synthesize a common lipid A species detected at ~m/z
1756, further investigation using collision induced dis-
sociation (CID) and 193 nm ultraviolet photodissocia-
tion (UVPD) MS/MS was conducted to elucidate the
V. cholerae lipid A structure (Fig. 3). Both of these
methods are complementary in that each yields unique
diagnostic fragmentation patterns, and when used
together, form a powerful tool for the structural character-
ization of lipid A and its modiﬁcations (Madsen et al.,
2011). For example, CID in general yields simple and
predictable spectra mostly from C-O cleavages that result
in neutral losses of phosphate groups and fatty acid
chains. UVPD, in contrast, yields a larger array of product
Incorporation of hydroxy fatty acids into V.cholerae LPS by LpxN 1315
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fatty acid chains as well as cross-ring and inter-ring
glucosamine cleavages. The cleavage of C-C bonds
adjacent to hydroxyl groups has also been shown to be
preferential upon UVPD (Madsen et al., 2011), further
cementing the utility of this method for the work herein.
Figure 3A shows the CID spectrum of singly deproto-
nated V. cholerae lipidAas well as its associated fragmen-
tation behaviour map, which matches the m/z-values of
observedfragmentionstospeciﬁccleavagesitesalongthe
structure. The combination of cleavages at the two phos-
phate groups, the inter-ring glucosamine that splits the
molecule and allows conﬁrmation that the distal side of the
molecule contains four acyl chains whereas the proximal
side contains only two. The C-O bonds at the 3- and
3′-linked primary acyl chains and 2′- and 3′-linked second-
ary acyl chains allow assignment of the general structure
of V. cholerae lipid A. UVPD of the doubly deprotonated
species (Fig. 3B) provides additional structural details,
including identiﬁcation of the key position of a hydroxyl
group. In particular, the formation of acyl chain ions of m/z
215.08 and 413.17 as well as the neutral loss of the
aliphatic tail adjacent to the secondary linked 3-OH C12:0
acyl chain (m/z 1627.58) suggests the presence of a
hydroxyl group on the 3-position of the 3′-linked secondary
acyl chain. However, due to the presence of a primary
linked3-OHC12:0acylchaininV. choleraelipidA,whichis
isobaric with the secondary linked 3-OH C12:0, additional
experiments described further in the Results were neces-
sary to determine the speciﬁc location of the hydroxyl
modiﬁcation. Overall, we were able to deduce that V. chol-
erae synthesize a bis-phosphorylated hexa-acylated lipid
A bearing two acyloxyacyl-linked acyl chains, a myristate
(C14:0) at the 2′-position and a probable b-hydroxylaurate
(3-OH C12:0) at the 3′-position (Fig. 3). These data further
corroborate our previous report which characterized the
V. choleraeLpxLhomologue,Vc0213,asamyristoyltrans-
ferase (Hankins and Trent, 2009).
Vc0212 (LpxN) functions as a lipid A acyltransferase
The Clusters of Orthologous Groups database (Tatusov
et al., 2000) identiﬁed three putative V. cholerae late acyl-
transferase homologues: Vc0212, Vc0213 and Vc1577.
Although the Clusters of Orthologous Groups database
recognized Vc1577 as a putative secondary acyltrans-
ferase, BLASTp results revealed that Vc1577 was an
unlikely LpxM homologue (E-value 3.9, 22% identity);
however, Vc0212 showed 41% identity (E-value of
< 10-64) when compared with the E. coli LpxM sequence.
Therefore, we hypothesized that Vc0212 functioned as a
lipid A secondary acyltransferase. In order to test this
hypothesis, a vc0212 deletion mutant was generated in
the V. cholerae O1 El Tor strain, E7946. The lipid A of
E7946 vc0212::kan was isolated and analysed by MALDI-
TOF MS, producing a major peak at m/z 1557.7 (Fig. 4A),
which corresponds to the loss of a 3-hydroxylaurate
(3-OH C12:0) residue from the predominant wild-type O1
El Tor lipid A species (Fig. 2A). MS/MS analysis by CID
indicated the absence of a 3-hydroxylaurate on the 3′-
linked acyl chain (Fig. S2) based on the m/z-values of the
corresponding products arising from cleavages of the
phosphate group, the inter-ring glucosamine, and the C-O
bonds along the primary and secondary acyl chains. Due
to the simplicity of this lipid A structure, the companion
UVPD analysis was not undertaken.
Additionally, the vc0212 transposon insertion was
obtained from a non-redundant transposon insertion
library in the V. cholerae O1 El Tor strain, C6706
(Cameron et al., 2008). MALDI-TOF analysis of lipid A
species isolated from the C6706 vc0212 transposon
insertion (Cameron et al., 2008) revealed a peak at m/z
1558.9 (data not shown), which was similar to the lipid
A species produced by E7946 vc0212::kan (Fig. 4A).
Together, these results are consistent with the loss of
3-hydroxylaurate (3-OH C12:0) from the wild-type
V. cholerae O1 El Tor lipidAstructure (Fig. 2) and indicate
that Vc0212 is indeed a functional V. cholerae secondary
acyltransferase. Notably, complementation of E7946 and
C6706 vc0212 mutations restored the hexa-acylated lipid
A phenotype in both O1 El Tor strains (Fig. S3).
V. cholerae LpxN is a novel lipid A secondary
acyltransferase
The genome of the Gram-negative bacterium Salmonella
typhimurium encodes the lipid A modifying enzyme LpxO,
which is responsible for modiﬁcation of the 3′-linked sec-
ondary acyl chain with a hydroxyl group at the 2-position.
LpxO, which is absent in E. coli, functions as a membrane
bound Fe2+/O2/a-ketoglutarate-dependent dioxygenase
that modiﬁes lipid A on the cytoplasmic face of the inner
membrane (Gibbons et al., 2000; 2005). Although the
genome of V. cholerae does not encode an LpxO homo-
logue according to BLASTp results, we wanted to deter-
mine if a previously unidentiﬁed lipid A dioxygenase was
responsible for the addition of the hydroxyl group of the
secondary laurate. To address this, ypO2063 of Yersinia
pestis was introduced into E7946 vc0212::kan using
plasmid pBADLpxMYP. The Yersinia protein was chosen
as it has been previously shown to transfer a lauroyl group
(C12:0) to the primary linked fatty acid at 3′-position of
lipid A (Rebeil et al., 2006). MALDI-TOF MS revealed a
major peak at m/z 1740.2 (Fig. 4B), which is consistent
with the addition of a non-hydroxy laurate to lipid A (pre-
dicted [M-H]- at m/z 1740.16). These data suggest that
the hydroxyl group at the 3-position of the fatty acyl chain
does not arise from an LpxO-like enzyme in V. cholerae.
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© 2011 Blackwell Publishing Ltd, Molecular Microbiology, 81, 1313–1329To conﬁrm that LpxN transfers a 3-hydroxylaurate to the
3′-linked primary acyl chain of V. cholerae lipid A, LpxN
was expressed in the E. coli lpxM deﬁcient strain,
MLK1067 (Table 2). The lipid A species of 32Pi-labelled
MLK1067 containing the empty vector pWSK29 or
pWVc0212 were isolated and separated via thin layer
chromatography (TLC). As expected MLK1067/pWSK29
synthesized a penta-acylated lipid A, bearing a single
secondary acyl chain at the 2′-position (Karow and Geor-
gopoulos, 1992) whereas expression of LpxN resulted in
the production of a faster migrating hexa-acylated lipid A
species (Fig. 5A). MALDI-TOF analysis of lipid A isolated
from MLK1067/pWSK29 yielded an expected peak at
m/z 1585.8 (Fig. 5B) indicating bis-phosphorylated,
penta-acylated lipid A [expected (M-H)- at m/z 1586.02].
However, MS analysis of lipid A isolated from MLK1067
expressing LpxN produced a peak at m/z 1783.6, a dif-
ference of 197.8 Da, thereby demonstrating that LpxN
catalyses the transfer of 3-hydroxylaurate to E. coli lipid A
(Fig. 5C).
To conﬁrm this lipid A structure, CID was performed on
the singly deprotonated ion, and UVPD was performed on
the doubly deprotonated ion as illustrated in Fig. S4. CID
again promoted C-O cleavages along the primary and
secondary acyl chains, at the phosphate groups, and
between the two glucosamines (Fig. S4A). The general
structure could be deduced from the CID spectrum alone;
however, the exact site of the hydroxylation could not be
pinpointed. Figure S4B illustrates the UVPD spectrum
and its associated fragmentation map. The additional
cleavages of C-C bonds along the fatty acid chain as well
as cross-ring and inter-ring glucosamine cleavages are
consistent with the structure shown in Fig. S4B. More
importantly, the UVPD spectrum conﬁrmed that the
hydroxylation occurs at the 3-position of the 3′-linked sec-
ondary acyl chain based on the pattern of preferential C-C
cleavage adjacent to the hydroxylation. This cleavage
denoted as (10) results in the neutral loss of the C9
aliphatic chain, which produces an ion (m/z 1655.67) that
is not isobaric with any other expected ion. Furthermore,
the product ion of m/z 441.25 (deprotonated 3′ acyl chain)
was subjected to CID (MS3) and yielded the fragment ion
of m/z 215.42 corresponding to the deprotonated 3-OH
lauric acid (Fig. 6).
Gas chromatography/mass spectrometry (GC/MS)
analysis of the trimethylsilylated (TMS) acyl chains from
whole LPS isolated from MLK1067 containing either
pWSK29 or pVc0212 also showed the location of the
hydroxyl group to reside at the 3-position of the laurate
(Fig. 7). Based upon the retention times of the standards
(Fig. S5), the esters obtained upon methanolysis and
silylation of the acyl chains of LPS from MLK1067/
pWSK29 corresponded to 3-hydroxymyristoylmethylester
(Fig. 7A), whereas LPS from MLK1067 expressing LpxN
(Vc0212) yielded the corresponding 3-hydroxylaurate
and 3-hydroxymyristate products (Fig. 7B). Electron ion-
ization (EI)/mass spectrometry of TMS derivatives from
E. coli expressing LpxN produced fragmentation patterns
showing the hydroxyl group at the 3-position of both
myristoyl (Fig. 7C) and lauroylmethylesters (Fig. 7D).
The EI mass spectra of the trimethylsilylated
2-hydroxylauroylmethylester and 2-hydroxymyristoyl-
methylester standards displayed different fragmentation
patterns as compared with the corresponding 3-hydroxy
derivatives (Fig. S5). Because wild-type E. coli lipid A
does not normally contain 3-hydroxylaurate, these
results conﬁrm not only the basic framework of the lipid
A species upon expression of LpxN, but also the exact
site of the hydroxylation on the 3-position of the second-
ary acyl chain.
Hydroxylation of the lipid A secondary acyl chain is
required for polymyxin B resistance of V. cholerae
Polymyxin B is a cationic antimicrobial peptide (CAMP)
that binds to the lipid A anchor of LPS, leading to the
disruption of the Gram-negative bacterial membrane.
Several Gram-negative bacteria possess lipidAmodifying
enzymes, which aid in survival against CAMPs (Trent
et al., 2006). V. cholerae serogroups O1 and O139 have
been shown to be resistant to polymyxin B (Gangarosa
et al., 1967; Higa et al., 1993), indicating that V. cholerae
may have evolved a lipid A structure to promote CAMP
resistance.
To determine if the presence of the 3-hydroxylaurate
(3-OH C12:0) residue on the V. cholerae lipid A structure
was important for the organism’s defence against
CAMPs, the minimum inhibitory concentration (MIC) of
polymyxin B was determined as described in Experimen-
tal procedures. As shown in Table 1, the loss of Vc0212
(LpxN) activity caused a 50-fold decrease in polymyxin
resistance when compared with wild-type levels, indicat-
ing that the presence of a 3-hydroxylaurate (3-OH C12:0)
was required for polymyxin B resistance in V. cholerae.
Complementation of E7946 vc0212::kan with vc0212,
restored polymyxin B resistance to wild-type levels.
Although expression of YpO2063 restored hexa-acylation
of Vibrio lipid A (Fig. 4B), it did not restore antimicrobial
peptide resistance (Table 1). This ﬁnding suggests that
the 3-hydroxyl group on the 3′-linked secondary acyl
chain is required for polymyxin resistance in V. cholerae.
Hexa-acylation of Vibrio LPS is required for stimulation
of TLR4
In order to determine if V. cholerae LPS possesses
immuno-stimulatory properties, LPS was puriﬁed using
the Hirschﬁeld method (Hirschﬁeld et al., 2000) that
1320 J. V. Hankins etal. 
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© 2011 Blackwell Publishing Ltd, Molecular Microbiology, 81, 1313–1329allows for removal of potential contaminating lipoproteins.
Activation of TLRs was monitored using HEK-Blue
293 cells stably transfected with TLR machinery and
a secreted embryonic alkaline phosphatase (SEAP)
reporter gene placed under the control of an NF-kB induc-
ible promoter allowing for easy detection of TLR activation
using a colorimetric assay. As shown in Fig. 8, wild-type
V. cholerae LPS causes a potent activation of hTLR4-
dependent NF-kB activation; however, LPS isolated
from the vc0212 deletion mutant with a penta-acylated
lipid A (Fig. 4A) is attenuated when assayed for hTLR4
activation. Interestingly, when the vc0212 deletion
mutant was complemented with a plasmid expressing
either LpxN (Vc0212) or the Yersinia enzyme, hTLR4-
dependent NF-kB stimulation returned to wild-type levels
(Fig. 8). When comparing hTLR4 activation using LPS
isolated from the vc0212 deletion mutant with LPS iso-
lated from wild type or complemented strains at concen-
trations between 1.0 and 1000 ng ml-1, hTLR4-dependent
NF-kB activation was signiﬁcantly reduced (P  0.006).
Within the literature there are reports of Gram-negative
organisms producing an LPS structure that activates
human TLR2 (hTLR2). Examples include LPS from Por-
phyromonas gingivalis (Darveau et al., 2004; Hashimoto
et al., 2004; Que-Gewirth et al., 2004; Ogawa et al., 2007)
and Leptospira interrogans (Werts et al., 2001). hTLR2
also recognizes other conserved bacterial structures
including lipoteichoic acid and lipoproteins (Hashimoto
et al., 2004; Ogawa et al., 2007). LPS from V. cholerae
did not activate HEK293 cells transfected with hTLR2
(Fig. S6). Altogether, these results indicate that the pres-
ence of an acyl chain linked at the 3′-position is required
for the stimulation of the innate immune system via
hTLR4-MD2. However, the 3-hydroxyl group does not
play a role in hTLR4 modulation. Furthermore, as is the
case with the vast majority of Gram-negative organisms,
LPS from V. cholerae did not stimulate hTLR2.
Discussion
Although several studies have characterized the fatty
acid compositions of V. cholerae LPS (Armstrong and
Redmond, 1974; Raziuddin and Kawasaki, 1976; Raziud-
din, 1977; Broady et al., 1981; Kabir, 1982), these ﬁndings
did not provide conclusive evidence for the proposed
V. cholerae Kdo-lipid A structures previously reported by
Chatterjee and Chaudhuri (2006) (Fig. S1) (Chatterjee
and Chaudhuri, 2006). V. cholerae serogroup O1 was pro-
posed to possess a symmetrical, hexa-acylated Kdo-lipid
A domain, bearing secondary acyl chains at the 2- and
2′-positions; however, V. cholerae O139 was reported as
having an octa-acylated Kdo-lipid A domain (Fig. S1). The
Fig. 6. MS
3 spectrum of lipid A isolated from E. coli MLK1067 expressing Vc0212. The doubly deprotonated lipid A ion (m/z 891.5) from
MLK1067 expressing Vc0212 was subjected to 193 nm UVPD (see Fig. S4) followed by CID of the fragment ion of m/z 441.4. The ion of m/z
441.4 is interpreted as the deprotonated intact 3′-acyloxyacyl moiety of lipid A (exact mass calculated to be 442.37 u, proposed structure
shown in the spectrum). The MS
3 fragment ion of m/z 215.42 is interpreted as deprotonated 3-hydroxylauric acid (exact mass 216.17 u,
proposed structure shown in the spectrum).
Table 1. Polymyxin minimal inhibitory concentration (MIC) of
V. cholerae strains.
Strain Polymyxin B MIC (mgm l
-1)
a
E7946 50.0
E7946 vc0212::kan 1.0
E7946 vc0212::kan, vc0212
+ 50.0
E7946 vc0212::kan, lpxMYP
+ 1.0
a. MIC values were identical for three biological replicates.
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received little attention until a previous report from our
laboratory investigated the late stages of V. cholerae Kdo-
lipid A biosynthesis (Fig. 1B) (Hankins and Trent, 2009).
Phosphorylation of the V. cholerae Kdo sugar was shown
to be required for the functionality of the V. cholerae sec-
ondary acyltransferase, Vc0213 (Fig. 1B). Vc0213 acts as
the V. cholerae LpxL homologue, transferring a myristate
(C14:0) to the phosphorylated Kdo-lipid A domain of
V. cholerae. Our ﬁndings herein identify the novel lipid A
secondary acyltransferase LpxN, encoded by vc0212,
which catalyses the transfer of 3-hydroxylaurate (3-OH
C12:0) to the 3′-linked acyl chain of V. cholerae lipid A.
Additionally, MS analysis of intact lipid A have provided a
deﬁnitive structure of a major lipid A species found on the
surface of V. cholerae serogroups responsible for human
disease.
Mass spectrometry analyses elucidated the predomi-
nant lipid A species of four V. cholerae strains associated
with cholera outbreaks: C6706, E7946, MO10 and O395
(Figs 2 and 3). Our ﬁndings demonstrated that V. cholerae
synthesize a b,1 ′-6 linked glucosamine disaccharide with
unmodiﬁed 1- and 4′-phosphate groups, which is acylated
at the 2-, 3-, 2′- and 3′-positions. Myristate (C14:0) and
3-hydroxylaurate (3-OH C12:0) are ester-linked to the
hydroxyl groups on the 2′- and 3′-linked fatty acyl chains,
creating an asymmetrical hexa-acylated lipid A (Figs 2
and 3). These results demonstrate that V. cholerae sero-
groups O1 and O139 synthesize a similar, asymmetrical
lipid A species that is different than the lipid A structures
reviewed by Chatterjee and Chaudhuri (2006).
LpxN was required for the transfer of a hydroxylated
secondary acyl chain to the 3′-linked acyl chain of the
glucosamine disaccharide (Fig. 3A). This ﬁnding was
further conﬁrmed by the heterologous expression of LpxN
in the E. coli lpxM mutant, MLK1067 (Figs 5–7). Although
lipid A secondary acyltransferases have been well char-
acterized in many Gram-negative bacteria, this is the ﬁrst
report to demonstrate the addition of a hydroxyl group to
the secondary acyl chain independent of LpxO.
A recent report found that V. cholerae vc0212 aids in
resistance to antimicrobial peptides, including polymyxin
B and LL-37 (Matson et al., 2010). However, MS analysis
reported by Matson and coworkers (2010) demonstrated
a hexa-acylated lipidApeak at m/z 1766.165 and a penta-
acylated peak at m/z 1539.971, which is inconsistent
Fig. 8. LPS from vc0212 deletion mutant does not stimulate innate immune recognition by human TLR4-MD2. HEK-293 cells transfected with
hTLR4-MD2 and co-receptor hCD14 were treated overnight using 10-fold dilutions of highly puriﬁed LPS isolated from the indicated strains of
V. cholerae. Additionally, LPS from R. sphaeroides (green line) and E. coli (black line) was utilized as negative and positive controls,
respectively. Values are the mean of results from triplicate wells  standard deviation. LPS isolated from the wild-type V. cholerae O1 El Tor
(blue line) was found to stimulate TLR4-dependent NF-kB activation in HEK cells, similarly to the positive control (black line). However, LPS
isolated from the vc0212 deletion mutant (orange line) did not elicit TLR4-dependent NF-kB activation. LPS isolated from the vc0212 deletion
mutant complemented with either vc0212 (red line) or the Y. pestis acyltransferase (magenta line) fully restored TLR-4 stimulation of NF-kB.
Wild-type LPS and LPS isolated from complemented strains at 1.0–1000 ng ml
-1 showed a signiﬁcant increase (P  0.006) in hTLR4-MD2
activation of NF-kB when compared with LPS isolated from the vc0212 deletion mutant. This ﬁgure is available in colour online at
wileyonlinelibrary.com.
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sistent with either of the proposed V. cholerae lipid A
structures for serogroups O1 and O139 (Fig. S1) and the
proposed structure by Matson and coworkers (2010). The
authors also reported a symmetrical lipid A structure for
serogroup O1 with a secondary acyl chain linked at the 2-
and 2′-positions. However, we have clearly demonstrated
that V. cholerae lipid A is asymmetrical with regard to its
acylation pattern (see structure in Fig. 1). Furthermore,
Matson et al. (2010) did not report the incorporation of
a secondary 3-hydroxylated fatty acyl chain, a unique
feature of V. cholerae LPS. Given that complementation
of the vc0212 mutant with the Yersinia lauroyl transferase
does not restore polymyxin resistance (Table 1), the incor-
poration of the 3-hydroxyl group provides a competitive
advantage for V. cholerae in the presence of CAMPs.
Interestingly, LPS isolated from V. cholerae strains
C6706 (El Tor) and O395 (classical) vc0212 mutants pre-
viously failed to stimulate hTLR4 (Matson et al., 2010);
however, complementation studies were not previously
reported. Here, we conﬁrm in the El Tor strain E7946 that
loss of hexa-acylation of V. cholerae LPS results in a
reduction in hTLR4 activation. Furthermore, through
complementation studies, we also demonstrate that
hTLR4 activation of the vc0212 deletion mutant can be
restored to wild-type levels when complemented in trans
with either V. cholerae or Y. pestis acyltransferases
(Fig. 8). These results indicate that the 3-hydroxyl group
on the 3′-linked acyl chain plays a differential role in
antimicrobial peptide resistance as compared with hTLR4
stimulation.
Other Gram-negative bacteria have been shown to syn-
thesize lipid A species that possess a hydroxyl group on a
secondary acyl chain. The lipid A structures of Salmonella
(Gibbonset al.,2000;2005),Pseudomonas(Kulshinet al.,
1991) and Legionella (Zahringer et al., 1995) contain
2-hydroxylations on the lipid A secondary acyl chains and
an LpxO homologue is encoded in each organism’s
genome. Although V. cholerae does not contain an LpxO
homologue, the organism has evolved an alternative
mechanism to obtain a hydroxylation on the lipidAsecond-
aryacylchain.Presumably,byutilizingb-hydroxylatedfatty
acid donors (e.g. acyl-acyl carrier proteins), Vc0212 can
catalysethetransferofa3-hydroxylaurate(3-OHC12:0)to
the lipid A domain of V. cholerae.
Interestingly, the lipid A species of the aquatic Gram-
negative bacteria, Marinomonas communis (Vorob’eva
et al., 2005) and Marinomonas vaga (Krasikova et al.,
2004), were also reported to synthesize lipid A species
containing hydroxylated secondary acyl chains. A recent
report on the lipid A structure of Vibrio ﬁscheri showed
a secondary 3-hydroxymyristate (3-OH C14:0) at the
2′-position (Phillips et al., 2011). A BLASTp search did not
reveal any LpxO homologues in the genomes of M. com-
munis, M. vaga or V. ﬁscheri similarly to V. cholerae.Thus,
the incorporation of a hydroxyl group to the lipidAof these
Gram-negative bacteria may occur by an LpxN hydroxy-
acyltransferase. The presence of a lipid A secondary
hydroxy-acyltransferase may also represent an important
evolutionary link among aquatic Gram-negative bacteria
and may play a key role in environmental or host survival.
These results together with our previous study (Hankins
and Trent, 2009) clarify the late stages of V. cholerae
Kdo-lipid A biosynthesis (Fig. 1B) and elucidate the
V. cholerae lipid A structure. Additionally, we have identi-
ﬁed a lipid A secondary acyltransferase, which promotes
polymyxin B resistance of V. cholerae. Although it is
unclear how the 3-hydroxyl group aids V. cholerae in
resistance to polymyxin B, Nikaido and coworkers
(Nikaido, 2003; Murata et al., 2007) have hypothesized
that LpxO activity may increase hydrogen bonding
between LPS molecules, thereby decreasing outer mem-
brane permeability. Further, the presence of a 3-hydroxyl
group on the secondary acyl chain may provide a site for
esteriﬁcation of additional functional groups. This is cur-
rently under investigation in our laboratory.
Experimental procedures
Bacterial strains and growth conditions
The bacterial strains and plasmids used in this study are
summarized in Table 2. V. cholerae strains were grown rou-
tinely at 37°C in Luria–Bertani (LB) broth or on LB agar or in a
modiﬁed g56 minimal media containing 45 mM HEPES, pH
7.5, 10 mM KCl, 10 mM (NH4)2SO4, 0.2% glucose, 1 mM
MgSO4, 1 mM CaCl2, 0.015 mM FeSO4, 0.075 mM thiamine
and 0.15 mM KH2PO4 (Galloway and Raetz, 1990). Typically,
E. coli strains were grown in LB at 37°C unless indicated
otherwise. Antibiotics were used at the following concentra-
tions:100 mgm l
-1ampicillin,60 mgm l
-1kanamycin,10 mgm l
-1
streptomycin. For V. cholerae complementation, 0.2% L-
arabinose (Acros Organics) was added to growth media.
Recombinant DNA techniques
Plasmids were isolated using the QIAprep Spin Miniprep Kit
(Qiagen). Custom primers were obtained from Integrated
DNA Technologies (Table S1). Polymerase chain reaction
(PCR) reagents were purchased from Takara, New England
Biolabs or Stratagene and PCR products were isolated using
QIAquick PCR Puriﬁcation Kit (Qiagen). DNAfragments were
isolated from agarose gels using the QIAquick Gel Extraction
Kit (Qiagen). All other modifying enzymes were purchased
from NEB and were used according to manufacturers’
instructions.
Construction of vc0212 defective mutant in V. cholerae
O1 El Tor strain, E7946
Vc0212 (lpxN) and 1000 bp ﬂanking sequence upstream and
downstream were ampliﬁed by PCR from N16961 genomic
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The amplicon was ligated into pGEM-T Easy (Promega),
creating pGEMVc0212. The vector, pGEMVc0212 was used
as template for inverse PCR (primers Fvc0212iPCR and
Rvc0212iPCR), which removed 670 bp from vc0212 and
inserted the restriction sites AvrII and AscI into the gene of
interest. The kanamycin resistance cassette (kan) from
pUC4K was obtained by PCR (KanF and 212KanR) and was
inserted into the AvrII and AscI sites of the inverse PCR
product, creating pGEMVc0212Kan. PCR was done to
amplify the vc0212::kan and the 1000 bp ﬂanking sequence
(primers Fvc0212pHM5 and Rvc0212pHM5) and the
amplicon was digested with BglII and ligated into the lpir-
dependent suicide vector, pHM5, creating pHM5Vc0212Kan.
pHM5Vc0212Kan was conjugated from SM10lpir into E7946
as described previously (Mey et al., 2005).
Complementation of E7946 and C6706 vc0212
defective mutants
The coding sequence of vc0212 (lpxN), including 20 nucle-
otides upstream of the vc0212 start codon, was PCR ampli-
ﬁed using primers Fvc0212pBAD and Rvc0212pBAD
(Table S1). The amplicon was digested with XbaI and SalI
and inserted into the arabinose inducible plasmid, pBAD18,
creating pBADVc0212. The plasmid pBADVc0212 was then
electroporated into the vc0212 mutants. The E7946 and
C6706 vc0212 mutants were also complemented with
pBADLpxMEC and pBADLpxMYP, which were cloned as
described above using primers found in Table S1.
Cloning vc0212 into the low-copy vector pWSK29
The vc0212 (lpxN) coding region, along with the pET21 ribo-
somal binding site, was excised from pVc0212 (Hankins and
Trent, 2009) using XbaI and XhoI. The gene fragment was
inserted into the low-copy vector pWSK29 (Wang and
Kushner, 1991) to yield pWVc0212. pWVc0212 was trans-
formed into XL-1 Blue for propagation. pWVc0212 was then
transformed into W3110 and MLK1067 to be used to isolate
lipid A species for radiolabelling and MS.
Isolation and visualization of 32P-labelled lipid A species
Seven millilitre cultures of MLK1067 and W3110 expressing
pWVc0212 or pWSK29 were started at an OD600 of ~0.05 in
LB at 30°C. Cultures were induced using 0.5 mM isopropyl-
Table 2. Bacterial strains and plasmids used in this study.
Strain or plasmid Genotype or description Source or reference
Strains
Vibrio cholerae
N16961 O1 El Tor biotype S. Payne
E7946 O1 El Tor biotype K. Klose
E7946 vc0212::kan E7946 with kanamycin resistance cassette in vc0212 This work
E7946 vc0212::kan, vc0212
+ vc0212::kan, pBADVc0212 This work
E7946 vc0212::kan, lpxMYP
+ vc0212::kan, pBADLpxMYP This work
E7946 vc0212::kan, lpxMEC
+ vc0212::kan, pBADLpxMEC This work
C6706 O1 El Tor biotype, lacZ
- Cameron et al. (2008)
C6706 Dvc0212 C6706 containing transposon insertion in vc0212 Cameron et al. (2008)
C6706 Dvc0212, vc0212
+ C6706 Dvc0212, pBADVc0212 This work
O395 O1 Classical biotype K. Klose
MO10 Wild-type O139 K. Klose
Escherichia coli
JM109 endA1, recA1, gyrA96, thi, hsdR17 (rk–, mk+), relA1, supE44, D(
lac-proAB), [F′ traD36, proAB, laqIqZDM15]
Promega
SM10lpir lpir recA Kan
r; host and mobilizing strain for pGP704 derivatives Miller and Mekalanos, 1988
XL-1 Blue recA1 endA1 gyrA96thi-1 hsdR17 supE44 relA1 lac [F′ proAB
lacI
qZDM15::Tn10 (Tet
R)]
Stratagene
W3110 Wild type, F
- l
- rph-1 INV(rrnD, rrnE)1 rph-1 E. coli Genetic Stock center (Yale)
MLK1067 W3110 lpxM::Wcam Karow and Georgopoulos (1992)
Plasmids
pET21a Vector containing a T7 promotor, Amp
r Novagen
pVc0212 pET21a containing vc0212 Hankins and Trent (2009)
pWSK29 Low-copy-number cloning vector, Amp
r Wang and Kushner (1991)
pWVc0212 pWSK29 containing vc0212 This work
pGEM-T Easy Vector containing a T7 promotor, Amp
r Promega
pGEMVc0212 pGEM-T Easy containing vc0212 This work
pGEMVc0212Kan pGEM-T Easy containing vc0212::kan This work
pUC4K Vector containing kan resistance gene Kan
r Pharmacia
pHM5 Suicide vector pGP704 carrying sacB; Amp
r Suc
S Runyen-Janecky et al. (1999)
pHM5Vc0212Kan pHM5 carrying vc0212::kan This work
pBAD18 Arabinose-inducible expression vector, Amp
r Guzman et al. (1995)
pBADVc0212 pBAD18 containing vc0212 This work
pBADLpxMYP pBAD18 containing Y. pestis lpxM (ypO2063) This work
1326 J. V. Hankins etal. 
© 2011 Blackwell Publishing Ltd, Molecular Microbiology, 81, 1313–1329b-D-thiogalactopyranoside (IPTG) (Fisher) and labelled using
2.5 mCi ml
-13 2 Pi (Perkin Elmer). Cells were harvested at an
OD600 of 1.0 by centrifugation and the isolation of
32P-labelled
lipid A carried out by mild acid hydrolysis as previously
described (Tran et al., 2006).
32P-lipid A species (10 000 cpm
per lane) were spotted onto a Silica Gel 60 TLC plate (EM
Separation Technology) and were separated using a solvent
system consisting of chloroform, pyridine, 88% formic acid
and water (50:50:16:5, v/v). TLC plates were exposed over-
night to a PhosphorImager screen, and
32P-labelled lipids
were detected and analysed using a Bio-Rad personal
molecular imager equipped with Quantity One software.
Large-scale isolation and MALDI-TOF MS of lipid A
Typically, V. cholerae (500 ml) and E. coli (200 ml) cultures
were grown at 37°C and 30°C, respectively, to an OD600 of
~1.0. Cells were harvested by centrifugation and lipid A was
released from cells and puriﬁed as previously described (Tran
et al., 2006). The lipid A species were analysed using a
MALDI-TOF/TOF(ABI4700ProteomicsAnalyzer)massspec-
trometer in negative and positive ion modes with the linear
detector as previously described (Hankins and Trent, 2009).
LipidAspeciesweredissolvedin5 mlofchloroform/methanol/
water (2:3:1, v/v) and were applied to a 1 ml DEAE-cellulose
(Whatman) column in the acetate form (Raetz and Kennedy,
1973; Raetz et al., 1985; Zhou et al., 1999). Five millilitres of
fractions were collected using chloroform/methanol/
increasing concentrations of aqueous ammonium acetate
(60 mM, 120 mM, 240 mM and 480 mM) (2:3:1, v/v). Each
fraction was then converted to two-phase Bligh/Dyer mixtures
by adding chloroform and methanol. The lower phases con-
taining the lipid A species were dried under N2 and stored at
-20°C.ThelipidAspecieswereanalysedusingaMALDI-TOF/
TOF (ABI 4700 Proteomics Analyzer) mass spectrometer in
negative and positive ion modes with the linear detector as
previously described (Hankins and Trent, 2009).
CID and UVPD MS of lipid A
All mass spectrometric experiments were undertaken on a
Thermo Fisher Scientiﬁc LTQ XL (San Jose, CA, USA)
equipped with a 193 nm Coherent ExciStar XS excimer
laser (Santa Clara, CA, USA). The setup was similar to that
previously described (Gardner et al., 2008; Madsen et al.,
2010). A q-value of 0.1 and UV photoirradiation consisting
of ﬁve pulses (8 mJ per pulse) at a 500 Hz rep rate (over a
10 ms period) were used for all UVPD experiments. For
CID, a q-value of 0.25, an activation time of 30 ms, and a
normalized collision energy of 35% were used. The
maximum injection time for all MS/MS spectra was set to
100 ms. An online nanoelectrospray setup was used for
direct infusion with the spray emitter operated at a voltage
of 2 kV. Details of the setup have been reported previously
(Madsen et al., 2011). Dried lipid A samples were reconsti-
tuted with 70 ml of 50/50 methanol/chloroform, and were
infused at 300 nl min
-1.
Polymyxin B MIC assay
Vibrio cholerae strains were grown overnight in LB media and
were diluted 1:100 in fresh LB. Cells were grown to an OD600
of ~0.5 and used to start fresh LB cultures at an OD600 of 0.05
containing increasing concentrations of polymyxin B (1, 2, 5,
10, 50, 100 and 200 mgm l
-1). Polymyxin B MICs were deter-
mined by assessing growth inhibition after 4 h at 37°C.
LPS isolation and puriﬁcation
Typically, V. cholerae (500 ml) cultures were grown at 37°C to
an OD600 of ~1.0. Cells were harvested by centrifugation and
lyophilized overnight. LPS was isolated using the phenol-
water method as described previously (Westphal and Jann,
1965). LPS samples were then further puriﬁed using the
method described by Hirschfeld and coworkers (2000) to
remove other contaminants (e.g. lipoproteins). Puriﬁed LPS
preparations were resuspended in endotoxin free water.
Gas chromatography/mass spectrometry analysis
For identiﬁcation of the fatty acyl chains of LPS, samples
were prepared as follows: ~1 mg of lyophilized LPS was
placed into a glass tube, followed by the addition of 800 mlo f
1 M methanolic HCl. The solution was incubated for 16 h at
80°C and the methanolysis product dried down under N2. The
sample was then per-O-trimethylsilylated by treatment with
250 ml Tri-Sil reagent (Pierce) at 80°C for 30 min. After
cooling, the sample was dried down followed by the addition
of 2 ml of hexane. After ﬁltering the solution through a glass
wool packed pasteur pipette, the ﬁltrate was dried down
under N2 until the volume was about 100 ml, from which 5 ml
was injected into an Agilent 7890 GC interfaced to a 5975C
MSD mass spectrometer operated in the electron ionization
mode. The separation was performed on a Grace EC-1 fused
silica capillary column (30 m ¥ 0.25 mm ID). Twenty microli-
tres of bacterial acid methylesters standard, supplied by
Matreya LLC (cat# 1114), was treated with 250 ml Tri-Sil
reagent (Pierce) at 80°C for 30 min and further processed
and analysed as described for the LPS samples.
TLR signalling assay
Human epithelial kidney (HEK) 293 cells stably transfected
with human TLR4, MD2 and CD14 (HEK-Blue-TLR4) were
purchased from InvivoGen. These HEK-Blue clones also
stably express secreted embryonic alkaline phosphatase
(SEAP) under the control of a promoter inducible by NF-kB
and activator protein 1 (AP-1). Thus, stimulation of hTLR4 will
result in an amount of extracellular SEAP in the supernatant
that is proportional to the level of NF-kB induction. The cells
were maintained in standard Dulbecco’s modiﬁed Eagle’s
medium (DMEM) with 10% heat-inactivated fetal bovine
serum (Gibco) supplemented with 4.5 g l
-1 glucose, 2 mM
L-glutamine, 50 U ml
-1 penicillin, 50 mgm l
-1 streptomycin,
100 mgm l
-1 Normocin (InvivoGen) and 1 ¥ HEK-Blue selec-
tion (InvivoGen) in a 5% saturated CO2 atmosphere at 37°C.
The induction of hTLR signalling in HEK-Blue-TLR4 cells
was assessed by measuring SEAP activity using QUANTI-
Blue colorimetric assay (InvivoGen). The assay was per-
formed according to manufacturer’s protocols. Brieﬂy, cells
were seeded in a 96-well plate in triplicate (2.5 ¥ 10
4 cells/
well) in the presence or absence of 10-fold dilutions of puri-
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(hTLR4 antagonist) (InvivoGen) and E. coli W3110 LPS
(hTLR4 agonist). After 20–24 h incubation, supernatants
(20 ml) were transferred to a 96-well plate and incubated for
1 h at 37°C with QUANTI-Blue (180 ml). SEAP activity was
measured by reading optical density at 655 nm with a
Synergy Mx multi-mode microplate reader (BioTek).
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